bayer drug may raise risk of death fda says associated press washington the food and drug administration said accumulating evidence suggests a bayer ag drug used to prevent excessive bleeding during heart bypass surgery increases the risk of death when compared with other drugs the announcement came as a canadian study comparing the safety and efficacy of the drug trasylol with two others was halted preliminary results from that trial also suggested trasylol increased the risk of death when compared with the other drugs trasylol works by blocking enzymes that dissolve blood clots bayer said it believes trasylol remains a safe and effective treatment option but that the company will work with the fda and regulators in other countries to re evaluate the drugs risks and benefits and determine where any label changes are needed 
